An in vitro experiment showed that the CDX2 gene is associated with the increase in sLex/a expression and suppression of FUT2 in colon cancer cells during EGF/bFGF-induced epithelial–mesenchymal transition (EMT) [40]. Here, CDX2 is linked to malignant colon neoplasm.